☆ 4.6 Editorial Material

Immunotherapy for NSCLC with oncogenic driver variants

FRONTIERS IN ONCOLOGY (2022)

Journal

FRONTIERS IN ONCOLOGY

Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fonc.2022.1095947

Keywords

oncogenic driver variants; tumor immune microenvironment; lung cancer; targeted therapy resistance; immune checkpoint inhibitors

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.